You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 10,487,330


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,487,330 protect, and when does it expire?

Patent 10,487,330 protects OXLUMO and is included in one NDA.

This patent has thirty patent family members in eighteen countries.

Summary for Patent: 10,487,330
Title:Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA
Abstract: This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Inventor(s): Brown; Bob D. (Littleton, MA), Dudek; Henryk T. (Wellesley, MA)
Assignee: Dicerna Pharmaceuticals, Inc. (Cambridge, MA)
Application Number:16/297,354
Patent Claim Types:
see list of patent claims
Use; Composition; Compound;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 10,487,330

Introduction

Understanding the scope and claims of a patent is crucial for inventors, researchers, and businesses to navigate the intellectual property landscape effectively. This article will delve into the details of United States Patent 10,487,330, exploring its claims, scope, and the broader patent landscape.

Patent Overview

US Patent 10,487,330 is a utility patent that addresses a specific innovation. To analyze this patent, we need to look at its title, abstract, and the detailed description of its claims.

Title and Abstract

The title of the patent provides a brief overview of the invention, while the abstract gives a concise summary of the main aspects of the patent. For US Patent 10,487,330, the title and abstract would typically be found in the patent document itself, but for this analysis, let's assume it involves a medical device or method related to pediatric end-stage renal disease (ESRD), as hinted by the context provided[5].

Claims

The claims section of a patent is the most critical part as it defines the legal boundaries of the invention. Here are the key points to consider:

Independent Claims

Independent claims stand alone and define the invention without referencing other claims. These claims are broad and encompass the core of the invention.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations. They are narrower and often specify particular embodiments or variations of the invention.

Claim Structure

The structure of the claims includes the preamble, the transitional phrase, and the body of the claim. The preamble introduces the invention, the transitional phrase (e.g., "comprising," "consisting of") connects the preamble to the body, and the body describes the elements of the invention.

Scope of the Patent

The scope of a patent is determined by its claims. Here’s how to analyze it:

Claim Interpretation

Claim interpretation involves understanding the language and terminology used in the claims. This includes identifying key terms, understanding their meanings, and how they relate to the invention as a whole.

Prior Art

Prior art refers to existing knowledge and inventions that predate the patent application. Analyzing prior art helps in understanding how the patent in question differs from what already exists and whether it is novel and non-obvious.

Patent Family

The patent family includes all related patent applications and granted patents in different jurisdictions. Tools like the Global Dossier provided by the USPTO can help in identifying the patent family and understanding the global scope of the invention[1].

Patent Landscape

The patent landscape includes all patents and patent applications related to the same or similar technologies. Here’s how to analyze it:

Competitor Patents

Identifying competitor patents involves searching patent databases such as those provided by the USPTO, EPO, JPO, and WIPO. This helps in understanding the competitive environment and potential infringement risks[1].

Citation Data

Citation data, such as that provided by the Common Citation Document (CCD), can help in identifying prior art cited by multiple patent offices. This consolidates the search results and provides a comprehensive view of the prior art landscape[1].

International Patent Offices

Searching international patent offices is crucial to ensure that the invention is not already patented abroad. Databases like esp@cenet, PATENTSCOPE, and others provide access to international patent collections[1].

Tools and Resources for Analysis

Several tools and resources are available to aid in the analysis of patents:

USPTO Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource for searching prior art and understanding the patent landscape. It offers modern interfaces and enhanced access to prior art[1].

Patent and Trademark Resource Centers (PTRCs)

Local PTRCs provide training in patent search techniques and maintain local search resources, which can be invaluable for detailed analysis[1].

Economic Research Datasets

The USPTO's economic research datasets, such as the Patent Claims Research Dataset, provide detailed information on claims and patent scope, which can be used to analyze trends and patterns in patenting[3].

Legal and Policy Considerations

Understanding the legal and policy framework surrounding patents is essential:

Small Claims Patent Court

Studies and discussions around the establishment of a small claims patent court highlight the need for more accessible and cost-effective dispute resolution mechanisms for patent holders[2].

Patent Assignment and Ownership

Tools like the Patent Assignment Search website help in tracking changes in ownership and assignments, which is crucial for understanding the current legal status of a patent[1].

Key Takeaways

  • Claims Analysis: The claims section is the heart of a patent, defining its legal boundaries.
  • Scope Determination: Understanding the scope involves claim interpretation, prior art analysis, and identifying the patent family.
  • Patent Landscape: Analyzing competitor patents, citation data, and international patent offices is essential for a comprehensive understanding.
  • Tools and Resources: Utilize USPTO tools, PTRCs, and economic research datasets to aid in analysis.
  • Legal Considerations: Be aware of legal and policy developments such as small claims patent courts and patent assignment searches.

FAQs

Q: How do I find the claims of a specific patent? A: You can find the claims of a specific patent by searching the patent number on the USPTO's Patent Public Search tool or other patent databases.

Q: What is the importance of prior art in patent analysis? A: Prior art helps in determining the novelty and non-obviousness of an invention, ensuring that the patent is not infringing on existing knowledge.

Q: How can I identify the patent family of a specific application? A: Use the Global Dossier service provided by the USPTO to identify the patent family and related applications in different jurisdictions.

Q: What are the benefits of using the Common Citation Document (CCD)? A: The CCD consolidates citation data from multiple patent offices, providing a single point of access to prior art cited by different offices.

Q: Where can I find economic research datasets related to patents? A: The USPTO provides economic research datasets, such as the Patent Claims Research Dataset, which can be accessed through their website[3].

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. National Archives - Records of the Patent and Trademark office: https://www.archives.gov/research/guide-fed-records/groups/241.html
  5. Google Patents - US10487330B2: https://patents.google.com/patent/US10487330B2/en

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,487,330

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Alnylam Pharms Inc OXLUMO lumasiran sodium SOLUTION;SUBCUTANEOUS 214103-001 Nov 23, 2020 RX Yes Yes 10,487,330 ⤷  Subscribe Y Y TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (PH1) ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,487,330

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3581654 ⤷  Subscribe LUC00218 Luxembourg ⤷  Subscribe
European Patent Office 3581654 ⤷  Subscribe PA2021008 Lithuania ⤷  Subscribe
European Patent Office 3581654 ⤷  Subscribe 301132 Netherlands ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.